Contribute Try STAT+ Today

Rise and shine, everyone, another busy day, and especially so here on the Pharmalot campus, where the short person remains hunched over a laptop, the official mascot is chasing wildlife, and we are scrambling to attack our to-do list. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. This calls, as you may imagine, for a hot cup of stimulation. We are enjoying salted caramel mocha today, a sweet reminder of the Jersey shore. Feel free to join us. Meanwhile, here are some tidbits. Hope your journey today is a smooth one. Meanwhile, stay safe and stay in touch. …

The top executives of Emergent BioSolutions (EBS), which ruined millions of doses of Covid-19 vaccine in a Baltimore plant in March, will testify to at a House subcommittee  at 10:30 a.m. ET today (you can watch here). A Food and Drug Administration inspection found serious violations, including failures to investigate instances of contamination, maintain sanitary conditions and sterile equipment, and lack of trained personnel. Emergent was awarded a $628 million contract last year to manufacture the vaccines but has not produced a single usable dose.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.